General MedicationsORALStandard
XPOVIO
SELINEXOR
Standard Dose
60MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview XPOVIO is listed in Drugs@FDA under application 212306 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SELINEXOR Form and strength TABLET;ORAL - 60MG Sponsor KARYOPHARM THERAPS Submission history Latest submission status date: 2025-09-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview XPOVIO is listed in Drugs@FDA under application 212306 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SELINEXOR Form and strength TABLET;ORAL - 60MG Sponsor KARYOPHARM THERAPS Submission history Latest submission status date: 2025-09-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.